Diabetic nephropathy (DN) is one of the leading complications resulting from chronic diabetes. It manifests as progressive renal failure caused by mesangial cell hyperplasia and fibrosis, and is one of the leading causes of terminal kidney disease (1). While the etiology is complex, an imbalance between pro- and anti-oxidant pathways in the kidney leading to an excess accumulation of reactive oxygen species (ROS) is believed to contribute in large part to the development of DN.
